EP2522354
Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.5.2011EP published:
23.8.2017EP application number:
11165869.6
EPO information:
European Patent Register
Max expiry date:
11.5.2031
Title:
Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
Timeline
Today
12.5.2011EP application
23.8.2017EP Publication
Owner
Name:
CSL Behring GmbHAddress:
Emil-von-Behring-Strasse 76, 35041, Marburg, DE
Inventor
Name:
Schulte, StefanAddress:
Marburg, DE
Name:
Kalina, UweAddress:
Marburg, DE
Name:
Moses, MichaelAddress:
Grävenwiesbach, DE
Name:
Feussner, AnnetteAddress:
Marburg, DE
Classification
Categories:
A61K 31/727, A61K 35/16, A61K 38/57, A61P 7/02, A61P 1/00, A61P 11/08, A61P 9/06, A61P 9/12